New medications for use in patients with rheumatoid arthritis
Author:
- 1 March 2000
- journal article
- review article
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 84 (3) , 280-287
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- A Trial of Etanercept, a Recombinant Tumor Necrosis Factor Receptor:Fc Fusion Protein, in Patients with Rheumatoid Arthritis Receiving MethotrexateNew England Journal of Medicine, 1999
- ANTI-TUMOR NECROSIS FACTOR-α MONOCLONAL ANTIBODY THERAPY FOR RHEUMATOID ARTHRITISRheumatic Disease Clinics of North America, 1998
- Treatment of Rheumatoid Arthritis with a Recombinant Human Tumor Necrosis Factor Receptor (p75)–Fc Fusion ProteinNew England Journal of Medicine, 1997
- Low‐dose corticosteroids in rheumatoid arthritis. A meta‐analysis of their moderate‐term effectivenessArthritis & Rheumatism, 1996
- Anticytokine treatment of established type II collagen–induced arthritis in DBA/1 mice: A comparative study using anti‐TNFα, anti–IL‐1α/β, and IL‐1RaArthritis & Rheumatism, 1996
- The Effect of Glucocorticoids on Joint Destruction in Rheumatoid ArthritisNew England Journal of Medicine, 1995
- Correlation between disease phenotype and genetic heterogeneity in rheumatoid arthritis.Journal of Clinical Investigation, 1995
- The American college of rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trialsArthritis & Rheumatism, 1993
- Comparison of low‐dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A Controlled Clinical TrialArthritis & Rheumatism, 1985
- Methotrexate therapy in rheumatoid arthritis: 15 years experienceThe American Journal of Medicine, 1983